rs2066865
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| Make rs2066865(C;T) |
| Make rs2066865(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 4 |
| Position | 154604124 |
| Gene | FGG |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2066865 |
| dbSNP (classic) | rs2066865 |
| ClinGen | rs2066865 |
| ebi | rs2066865 |
| HLI | rs2066865 |
| Exac | rs2066865 |
| Gnomad | rs2066865 |
| Varsome | rs2066865 |
| LitVar | rs2066865 |
| Map | rs2066865 |
| PheGenI | rs2066865 |
| Biobank | rs2066865 |
| 1000 genomes | rs2066865 |
| hgdp | rs2066865 |
| ensembl | rs2066865 |
| geneview | rs2066865 |
| scholar | rs2066865 |
| rs2066865 | |
| pharmgkb | rs2066865 |
| gwascentral | rs2066865 |
| openSNP | rs2066865 |
| 23andMe | rs2066865 |
| SNPshot | rs2066865 |
| SNPdbe | rs2066865 |
| MSV3d | rs2066865 |
| GWAS Ctlg | rs2066865 |
| GMAF | 0.3186 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 20167083
] Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study
[PMID 20709368] The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease
[PMID 22707612] Genetic Risk Factors for Thrombosis in Systemic Lupus Erythematosus
[PMID 16144795] Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
[PMID 17445871] The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
[PMID 21422408] Clotting factor gene polymorphisms and colorectal cancer risk.
[PMID 23150947] Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study
[PMID 25091233] Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia
[PMID 25210051] Genetic Variations Associated with Recurrent Venous Thrombosis
| ClinVar | |
|---|---|
| Risk | rs2066865(T;T) |
| Alt | rs2066865(T;T) |
| Reference | Rs2066865(C;C) |
| Significance | Non-pathogenic |
| Disease | Afibrinogenemia |
| Variation | info |
| Gene | FGG |
| CLNDBN | Afibrinogenemia, congenital |
| Reversed | 1 |
| HGVS | NC_000004.11:g.155525276G>A |
| CLNSRC | |
| CLNACC | RCV000361528.1, |
[PMID 29094466] Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: The Tromsø Study.
[PMID 30773804] Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke.The TromsØ Study.
[PMID 32110755] Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study.
[PMID 31484330] Polymorphism rs2066865 in the Fibrinogen Gamma Chain (FGG) Gene Increases Plasma Fibrinogen Concentration and Is Associated with an Increased Microvascular Thrombosis Rate.
[PMID 32402998] Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
[PMID 32671915] Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.
